All Pharma News
Synthon Pharma`s Generic Gefitinib Receives Tentative Approval In US

Synthon Pharma`s Generic Gefitinib Receives Tentative Approval In US
FDA
27 Nov 2020
Share Share
Byondis Initiates Ph I Study of ADC [Vic-]Trastuzumab Duocarmazine + Niraparib

Byondis Initiates Ph I Study of ADC [Vic-]Trastuzumab Duocarmazine + Niraparib
PRESS RELEASE
24 Aug 2020
Share Share
Synthon Biopharmaceuticals Relaunches as Byondis

Synthon Biopharmaceuticals Relaunches as Byondis
BUSINESSWIRE
15 Apr 2020
Share Share
Fentanyl : Insys Therapeutics vs. Teva Pharmaceutical

Fentanyl : Insys Therapeutics vs. Teva Pharmaceutical
PATENT LITIGATION
24 Nov 2018
Share Share
Pomalyst® (Pomalidomide Capsules) : Celgene Corporation v. Synthon

Pomalyst® (Pomalidomide Capsules) : Celgene Corporation v. Synthon
PATENT LITIGATION
21 Jun 2018
Share Share
US FDA grants fast track status to Synthon’s trastuzumab duocarmazine

US FDA grants fast track status to Synthon’s trastuzumab duocarmazine
PHARMABIZ
01 Feb 2018
Share Share
Synthon`s generic version of Copaxone 40mg approved in Europe

Synthon`s generic version of Copaxone 40mg approved in Europe
G. Macdonald IN PHARMATECHNOLOGIST
06 Oct 2017
Share Share
Regulatory approval in Europe granted for Synthon`s Glatiramer Acetate

Regulatory approval in Europe granted for Synthon`s Glatiramer Acetate
BIOSPECTRUM
05 Oct 2017
Share Share
Updated: Copaxone Generics: Who Will Win First Filer Exclusivity?

Updated: Copaxone Generics: Who Will Win First Filer Exclusivity?
Zachary Brennan RAPS
04 Oct 2017
Share Share
Synthon says EPO appeal board has revoked Copaxone API patent

Synthon says EPO appeal board has revoked Copaxone API patent
G. MacDonald IN PHARMATECHNOLOGIST
13 Sep 2017
Share Share